Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples
Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Liquid chromatography-tandem mass spectrometry was used to analyze plasma proteins of volunteers (control) and patients with glioblastoma multiform (GBM). A database search was pre-set with a variable post-translational modification (PTM): phosphorylation, acetylation or ubiquitination. There were no significant differences between the control and...
Alternative Titles
Full title
Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1897800127
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1897800127
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0177427
